These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2174933)

  • 21. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
    Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC.
    Pelletier G; Ducreux M; Gay F; Luboinski M; Hagège H; Dao T; Van Steenbergen W; Buffet C; Rougier P; Adler M; Pignon JP; Roche A
    J Hepatol; 1998 Jul; 29(1):129-34. PubMed ID: 9696501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization.
    Stuart K; Stokes K; Jenkins R; Trey C; Clouse M
    Cancer; 1993 Dec; 72(11):3202-9. PubMed ID: 7694787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Limitation of oily chemoembolization against hepatocellular carcinoma and arterioportal segmental chemoembolization].
    Nakamura H; Hashimoto T; Fujita M; Oi H; Inoue K; Mizumoto S; Sawada S; Takayasu Y; Hori S; Furui S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2849-52. PubMed ID: 2551227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma.
    Seong J; Keum KC; Han KH; Lee DY; Lee JT; Chon CY; Moon YM; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):393-7. PubMed ID: 10030267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of hepatic artery embolization: comparison between Gelfoam and Lipiodol with anticancer agent.
    Yamashita Y; Takahashi M; Fujimura N; Kan M
    Radiat Med; 1987; 5(3):61-7. PubMed ID: 2447611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transarterial segmental hepatic chemo-embolization in patients with hepatocellular carcinoma].
    Nakamura H; Hashimoto T; Inoue K; Futami Y; Mizumoto S; Monden M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2540-3. PubMed ID: 2843120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-I: hepatic arterial embolization and embolization-based therapies in unresectable hepatocellular carcinoma.
    Reidy DL; Schwartz JD
    Anticancer Drugs; 2004 Jun; 15(5):427-37. PubMed ID: 15166616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam.
    Ngan H; Lai CL; Fan ST; Lai EC; Yuen WK; Tso WK
    Clin Radiol; 1993 May; 47(5):315-20. PubMed ID: 8389682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
    Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
    Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
    Chung JW; Park JH; Han JK; Choi BI; Han MC
    AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
    Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular carcinoma in cirrhosis.
    Audisio RA; Doci R; Mazzaferro V; Bellegotti L; Tommasini M; Montalto F; Marchianò A; Piva A; DeFazio C; Damascelli B
    Cancer; 1990 Jul; 66(2):228-36. PubMed ID: 2164435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
    Llovet JM; Real MI; Montaña X; Planas R; Coll S; Aponte J; Ayuso C; Sala M; Muchart J; Solà R; Rodés J; Bruix J;
    Lancet; 2002 May; 359(9319):1734-9. PubMed ID: 12049862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.